Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

NCT01134380 is registered in ClinicalTrials.gov with Biotronik France as lead sponsor.

NCT NCT01134380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01134380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Lead sponsor
Biotronik France
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
March 31, 2013
Enrollment
1,500 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, compliance to thienopyridine treatment, coronary artery disease, genetic resistance to clopidogrel